Ann: Cynata Enters Letter of Intent for a Commercial Partnership, page-23

This mob is Germany has great background and their networks in Europe i suspect will be invaluable for CYP .............In 2005, Andreas Struengmann and his twin brother, Thomas, who together founded generic drug maker Hexal AG in 1986, sold the business (along with their 68% stake in U.S.-based Eon Labs) to Novartis for $7.5 billion. Since then, they've been investing primarily in biotechnology and health companies. Their holdings also include a private bank, Stuttgart-based Sudwestbank. In 2008, they established a neuroscience research center in Frankfurt named after their father, Ernst Struengmann.